Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Plasma cell 4Other hematologic neoplasm 4Other neoplasm 3Dermatologic 3Classical hematology 3Thoracic 1Breast 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Anemia 1

Interventions

pembrolizumab 7Cyclophosphamide 7Surveys and Questionnaires 4Filgrastim 4aldesleukin 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Nivolumab 3Methods 3Flow Cytometry 3Early Intervention, Educational 3valspodar 2sargramostim 2fludarabine 2atezolizumab 2Therapeutics 2Stem Cell Factor 2Sirolimus 2Methylprednisolone 2Melphalan 2Ipilimumab 2Interleukin-2 2Immunologic Techniques 2Exercise 2Etoposide 2Epoetin Alfa 2Educational Status 2Drug Therapy 2Data Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Darbepoetin alfa × Breast × Clear all
NCT00036023 2009-05-11

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Amgen

Phase 2 Completed
BreastLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡